Previous 10 | Next 10 |
High-growth stocks often capitalize on emerging trends and new technologies. But with a world of fast-evolving tech out there, it can sometimes be tricky to identify likely growth stocks . One way to do it, though, is to look at emerging trends and see what companies are likely to benefit. ...
Welcome to a new month. Kids are back in school. Football has cranked back up. Fall will soon be in the air. It's a great time to... buy stocks. You might be thinking, "But what about the trade war with China? What about the inverted yield curve? Could a recession be on the way?" Those mi...
Shares of Guardant Health (NASDAQ: GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. The medical diagnostics provider's stock was down 9.4% as of 1:10 p.m. EDT, washing away the gains produced by the exciting second-quarte...
Insider buying declined significantly last week with insiders purchasing $67.39 million of stock last week compared to $283.3 million in the week prior. Selling, on the other hand, increased with insiders selling $1.65 billion of stock last week compared to $1.6 billion in the week prior. S...
ShockWave Medical (NASDAQ: SWAV) and Guardant Health (NASDAQ: GH) both came public in the last year and are off to a fast start. Each of these businesses is growing at a triple-digit rate, and both companies boosted their full-year guidance after reporting expectation-smashing results. ...
I worked in the healthcare sector for most of my career. I write about healthcare stocks nearly every day. A significant chunk of my personal portfolio is invested in healthcare stocks as well. My view is that the sector remains one of the best areas to invest in . Every now and then, someone ...
On this week's episode of Industry Focus: Healthcare , host Shannon Jones and Motley Fool contributor Brian Feroldi catch listeners up on four companies we've talked about before: Abiomed (NASDAQ: ABMD) , Inogen (NASDAQ: INGN) , Guardant Health (NASDAQ: GH) , and Shoc...
At the end of the day, a stock is simply a share in the ownership of a business, and market prices are reflecting a particular set of expectations about the earnings power of such a business. If the company can prove to investors that it can consistently do better than expected, then the stock...
With the S&P 500 down 6% by the middle of last week from its all-time peak set on July 26th, insiders stepped up their buying significantly, resulting in a number of interesting insider purchases. Insider buying more than doubled last week, with insiders purchasing $283.3 million of stock ...
Now China claims US broke the negotiation agreement The market futures plunge after China threatens retaliation. Then China backtracks, and the market goes back up. China claims the US broke the agreement; we say China did. Am I the only one who is bored with the whole nonsense? All I can ...
News, Short Squeeze, Breakout and More Instantly...
Tuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH) experimental bloo...
Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption of guideline-recommended genomic profiling to inform optimal therapy selection for p...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting in Washington, DC, highlighting the value of the company’s Shield™ test in colorectal cancer (C...